Patient identifier: (b)(6).
Completed information: (b)(6).
No further patient information was provided by the customer.
An evaluation is in process.
A follow-up report will be submitted when the evaluation is complete.
This report is being filed on an international product, list number 6c29 that has a similar product distributed in the us, list number 6l27.
|
The customer observed false reactive architect havab-igg results for multiple samples.
Additionally, the customer reported inconsistent values for the assay between their two architect analyzers (serial numbers (b)(4)) including the control material.
The customer completed a weekly repeat of the following sample on both analyzers.
The customer believes the samples were stored correctly prior to the repeat testing.
It is unknown which analyzer generated the initial results (units of measure = s/co, reference range: greater than or equal to 1.
0 s/co = reactive): (b)(6) 2020; sid: (b)(6) original result = 0.
83, repeats on isr53089 = 0.
83, 1.
00, and 1.
03, repeats on isr53090 = 0.
85, 0.
86, and 0.
88 no impact to patient management was reported.
|